Company Data

RenovoRx Inc.

Ticker
RNXT
Current Price
$1.03 -8.04%
Market Cap
$24.7M
Price Target
Refer to Report
Volume
262.5K
52wk Range
$0.7736 - $1.86
Advanced Market Data

Overview

RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy